Inhibition of endothelial adhesion molecule expression by Monascus purpureus-fermented rice metabolites, monacolin K, ankaflavin, and monascin

Journal of the Science of Food and Agriculture

Volumn 91, Issue 10, 2011, Pages 1751-1758

  Lin, Chih Pei ^a,b   Lin, Yun Lian ^c   Huang, Po Hsun ^a,b   Tsai, Hui Szu ^a   Chen, Yung Hsiang ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cell adhesion molecule; Inflammation; Monascus purpureus rice (red yeast rice); Nuclear factor B; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ANKAFLAVIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUSED HETEROCYCLIC RINGS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEVINOLIN; MONASCIN; REACTIVE OXYGEN METABOLITE; RIBOFLAVIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AORTA; ARTICLE; CELL ADHESION; CELL LINE; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; FERMENTATION; HUMAN; METABOLISM; MICROBIOLOGY; MONASCUS; RICE;

ACETYLCYSTEINE; AORTA; CELL ADHESION; CELL LINE; E-SELECTIN; ENDOTHELIAL CELLS; FERMENTATION; FLAVINS; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; LOVASTATIN; MONASCUS; NF-KAPPA B; ORYZA SATIVA; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

MONASCUS; MONASCUS PURPUREUS;

EID: 79959301944     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.4371     Document Type: Article

References (45)

1. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM and Go VL, Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 69: 231-236 (1999).
2. Man RY, Lynn EG, Cheung F, Tsang PS and O K, Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2). Mol Cell Biochem 233: 153-158 (2002).
3. Wei W, Li C, Wang Y, Su H, Zhu J and Kritchevsky D, Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits. J Nutr Biochem 14: 314-318 (2003).
4. Ma J, Li Y, Ye Q, Li J, Hua Y, Ju D, et al, Constituents of red yeast rice, a traditional Chinese food and medicine. J Agric Food Chem 48: 5220-5225 (2000).
5. Zhang W, Duan Z and X S, Active components of Xuezhikang. Chinese J New Drugs 7: 213-214 (1998).
6. Katan MB, Zock PL and Mensink RP, Effects of fats and fatty acids on blood lipids in humans: an overview. Am J Clin Nutr 60: 1017S-1022S (1994).
7. Martinkova L, Patakova-Juzlova P, Krent V, Kucerova Z, Havlicek V, Olsovsky P, et al, Biological activities of oligoketide pigments of Monascus purpureus. Food Addit Contam 16: 15-24 (1999).
8. Lin YL, Wang TH, Lee MH and Su NW, Biologically active components and nutraceuticals in the Monascus-fermented rice: a review. Appl Microbiol Biotechnol 77: 965-973 (2008).
9. Journoud M and Jones PJ, Red yeast rice: a new hypolipidemic drug. Life Sci 74: 2675-2683 (2004).
10. Su YC, Wang JJ, Lin TT and Pan TM, Production of the secondary metabolites gamma-aminobutyric acid and monacolin K by Monascus. J Ind Microbiol Biotechnol 30: 41-46 (2003).
11. Taira J, Miyagi C and Aniya Y, Dimerumic acid as an antioxidant from the mold, Monascus anka: the inhibition mechanisms against lipid peroxidation and hemeprotein-mediated oxidation. Biochem Pharmacol 63: 1019-1026 (2002).
12. Yamashiro J, Shiraishi S, Fuwa T and Horie T, Dimerumic acid protected oxidative stress-induced cytotoxicity in isolated rat hepatocytes. Cell Biol Toxicol 24: 283-290 (2008).
13. Aniya Y, Ohtani, II, Higa T, Miyagi C, Gibo H, Shimabukuro M, et al, Dimerumic acid as an antioxidant of the mold, Monascus anka. Free Radic Biol Med 28: 999-1004 (2000).
14. Dhale MA, Divakar S, Kumar SU and Vijayalakshmi G, Isolation and characterization of dihydromonacolin-MV from Monascus purpureus for antioxidant properties. Appl Microbiol Biotechnol 73: 1197-1202 (2007).
15. Lee CL, Wang JJ, Kuo SL and Pan TM, Monascus fermentation of dioscorea for increasing the production of cholesterol-lowering agent-monacolin K and antiinflammation agent-monascin. Appl Microbiol Biotechnol 72: 1254-1262 (2006).
16. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389 (1994).
17. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22 (2002).
18. Gotto AM Jr and Farmer JA, Pleiotropic effects of statins: do they matter? Curr Opin Lipidol 12: 391-394 (2001).
19. Takemoto M and Liao JK, Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21: 1712-1719 (2001).
20. Zhao SP, Liu L, Cheng YC and Li YL, Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease. Atherosclerosis 168: 375-380 (2003).
21. Aniya Y, Yokomakura T, Yonamine M, Shimada K, Nagamine T, Shimabukuro M, et al, Screening of antioxidant action of various molds and protection of Monascus anka against experimentally induced liver injuries of rats. Gen Pharmacol 32: 225-231 (1999).
22. Liu L, Zhao SP, Cheng YC and Li YL, Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease. Clin Chem 49: 1347-1352 (2003).
23. Zhao SP, Liu L, Cheng YC, Shishehbor MH, Liu MH, Peng DQ, et al, Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation 110: 915-920 (2004).
24. Li JJ, Hu SS, Fang CH, Hui RT, Miao LF, Yang YJ, et al, Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina. Clin Chim Acta 352: 217-224 (2005).
25. Hu CL, Li YB, Tang YH, Chen JB, Liu J, Tang QZ, et al, Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease. Cardiovasc Drugs Ther 20: 185-191 (2006).
26. Zhao SP, Lu ZL, Du BM, Chen Z, Wu YF, Yu XH, et al, Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS). J Cardiovasc Pharmacol 49: 81-84 (2007).
27. Chen YH, Lin SJ, Chen YL, Liu PL and Chen JW, Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets 6: 279-304 (2006).
28. Ross R, Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126 (1999).
29. Puddu GM, Cravero E, Arnone G, Muscari A and Puddu P, Molecular aspects of atherogenesis: new insights and unsolved questions. J Biomed Sci 12: 839-853 (2005).
30. Lin CP, Chen YH, Chen JW, Leu HB, Liu TZ, Liu PL, et al, Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-kappa B activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells. J Biomed Sci 15: 183-196 (2008).
31. Koga T, Claycombe K and Meydani M, Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 161: 365-374 (2002).
32. Silverman MD, Tumuluri RJ, Davis M, Lopez G, Rosenbaum JT and Lelkes PI, Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 22: 587-592 (2002).
33. Welder AA, A primary culture system of adult rat heart cells for the evaluation of cocaine toxicity. Toxicology 72: 175-187 (1992).
34. Chen JW, Chen YH, Lin FY, Chen YL and Lin SJ, Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler Thromb Vasc Biol 23: 1559-1566 (2003).
35. Chen YH, Lin SJ, Chen JW, Ku HH and Chen YL, Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol 135: 37-47 (2002).
36. Tsai CH, Chang RC, Chiou JF and Liu TZ, Improved superoxide-generating system suitable for the assessment of the superoxide-scavenging ability of aqueous extracts of food constituents using ultraweak chemiluminescence. J Agric Food Chem 51: 58-62 (2003).
37. Tsai CH, Stern A, Chiou JF, Chern CL and Liu TZ, Rapid and specific detection of hydroxyl radical using an ultraweak chemiluminescence analyzer and a low-level chemiluminescence emitter: application to hydroxyl radical-scavenging ability of aqueous extracts of food constituents. J Agric Food Chem 49: 2137-2141 (2001).
38. Chen CW, Chiou JF, Tsai CH, Shu CW, Lin MH, Liu TZ, et al, Development of probe-based ultraweak chemiluminescence technique for the detection of a panel of four oxygen-derived free radicals and their applications in the assessment of radical-scavenging abilities of extracts and purified compounds from food and herbal preparations. J Agric Food Chem 54: 9297-9302 (2006).
39. Lin CP, Chen YH, Leu HB, Lin SJ, Chen YL, Huang SL, et al, Anti-inflammatory strategies for homocysteine-related cardiovascular disease. Front Biosci 14: 3836-3845 (2009).
40. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, et al, Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107: 675-683 (2001).
41. Franzoni F, Quinones-Galvan A, Regoli F, Ferrannini E and Galetta F, A comparative study of the in vitro antioxidant activity of statins. Int J Cardiol 90: 317-321 (2003).
42. Haendeler J, Hoffmann J, Zeiher AM and Dimmeler S, Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation 110: 856-861 (2004).
43. Jung H, Kim C, Kim K and Shin CS, Color characteristics of Monascus pigments derived by fermentation with various amino acids. J Agric Food Chem 51: 1302-1306 (2003).
44. Krejsa CM, Nadler SG, Esselstyn JM, Kavanagh TJ, Ledbetter JA and Schieven GL, Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors: redox independent activation of NF-kappa B. J Biol Chem 272: 11541-11549 (1997).
45. Janssen-Heininger YM, Poynter ME and Baeuerle PA, Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28: 1317-1327 (2000).